ReNeuron Group Plc (LON:RENE)’s share price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $205.02 and traded as low as $185.00. ReNeuron Group shares last traded at $195.00, with a volume of 50,404 shares.
The business’s 50 day moving average price is GBX 218.55 and its 200-day moving average price is GBX 205.02. The firm has a market capitalization of $62.07 million and a price-to-earnings ratio of -4.31.
ReNeuron Group (LON:RENE) last issued its quarterly earnings results on Thursday, July 11th. The company reported GBX (45.20) (($0.59)) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of GBX (49.80) (($0.65)) by GBX 4.60 ($0.06).
ReNeuron Group plc develops and sells cell-based therapies in the United Kingdom. The company's lead therapeutic candidate is CTX stem cell therapy, which has been completed Phase II clinical trial for the treatment of patients living with chronic disability following stroke, as well as that has been completed Phase I clinical trial to treat limb ischaemia.
Further Reading: How analysts view the yield curve
Receive News & Ratings for ReNeuron Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReNeuron Group and related companies with MarketBeat.com's FREE daily email newsletter.